Does DEMCIZUMAB Cause Disease progression? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Disease progression have been filed in association with DEMCIZUMAB. This represents 10.9% of all adverse event reports for DEMCIZUMAB.
15
Reports of Disease progression with DEMCIZUMAB
10.9%
of all DEMCIZUMAB reports
3
Deaths
0
Hospitalizations
How Dangerous Is Disease progression From DEMCIZUMAB?
Of the 15 reports, 3 (20.0%) resulted in death.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEMCIZUMAB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does DEMCIZUMAB Cause?
Non-small cell lung cancer (18)
Pancreatic carcinoma metastatic (12)
Drug ineffective (11)
Dehydration (10)
Off label use (10)
Pancytopenia (10)
Hypotension (8)
Metastases to central nervous system (8)
Metastases to liver (8)
Peroneal nerve palsy (7)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which DEMCIZUMAB Alternatives Have Lower Disease progression Risk?
DEMCIZUMAB vs DEMEROL
DEMCIZUMAB vs DENOSUMAB
DEMCIZUMAB vs DEOXYCHOLIC ACID
DEMCIZUMAB vs DEPAKINE CHRONO
DEMCIZUMAB vs DEPAKOTE